Bipartisan Letter Expresses Concerns About Naloxone Shortages to Merrick Garland

May 2, 2022

Congressional members of both parties have penned a letter to Attorney General Merrick Garland regarding their concerns over recent settlements with Teva Pharmaceuticals for its role in the opioid overdose epidemic. Marcy Kaptur (D-OH) and Andy Harris (R-MY) argue that the proposed plan to let Teva pay its settlements by supplying the overdose reversal drug naloxone could create potentially fatal supply bottlenecks.

According to Zachary Brennan of Endpoints News, “Most recently, Teva agreed to pay part of its settlement with the state of Florida by providing generic Narcan (naloxone hydrochloride nasal spray) valued at $84 million (wholesale acquisition cost) over 10 years. Rhode Island’s AG similarly agreed to a deal where Teva will supply 50,000 kits of Naloxone (100,000 nasal sprays) per year for 10 years, valued at $62.5 million, as well as opioid treatment Suboxone valued at $16 million over 10 years.  And in Texas, the state will get $75 million worth of Narcan from Teva over 10 years.”

To learn more, click here.

(Source: Endpoints News, May 2nd, 2022)

Share This Story!